On 19 December 2011, Alliance Pharma plc announced that its wholly owned subsidiary Alliance Pharmaceuticals Limited acquired the brands Quinoderm™ and Ceanel™ from Ferndale Pharmaceuticals Limited for £1.5 million.
Alliance Pharmaceuticals Limited was advised in this transaction by Fasken Martineau with a team that included Chris Chrysanthou, Paul Ranson, Antonina Nijran, Stephen Callender and Sharmela Thevarajaha.